Katsuhiko Naoki

16.8k citations
125 papers · 11.6k indexed · 1 hit paper · h-index 33
Topics
Lung Cancer Treatments and Mutations (65 papers)Lung Cancer Research Studies (39 papers)Colorectal Cancer Treatments and Studies (19 papers)
Partner nations
JapanUnited StatesFrance

In The Last Decade

Katsuhiko Naoki

123 papers receiving 11.3k citations

Hit Papers

EGFR Mutations in Lung Cancer: Correlation with Clinical ...200420262011201820042.5k5.0k7.5k

Peers

Katsuhiko Naoki
Comparison fields: 5 of 133
  • Pulmonary and Respiratory Medicine 7.5k
  • Oncology 6.2k
  • Molecular Biology 5.0k
  • Cancer Research 2.7k
  • Pathology and Forensic Medicine 811
Replace Ross A. Okimoto with:
Ross A. Okimoto United States
Balázs Halmos United States
Hidefumi Sasaki Japan
Isamu Okamoto Japan
Toyoaki Hida Japan
Daniel Morgensztern United States
Nobuyuki Yamamoto Japan
Tarek Mekhail United States
Seiji Yano Japan
Tim Eisen United Kingdom
Katsuhiko Naoki relative to Ross A. Okimoto United States Ross A. Okimoto's profile →
Citations per field
00.5×1.5×
Ross A. Okimoto · 1×
Citations per year

Countries citing papers authored by Katsuhiko Naoki

Since Specialization
Citations

This map shows the geographic impact of Katsuhiko Naoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuhiko Naoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuhiko Naoki more than expected).

Fields of papers citing papers by Katsuhiko Naoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuhiko Naoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuhiko Naoki. The network helps show where Katsuhiko Naoki may publish in the future.

Co-authorship network of co-authors of Katsuhiko Naoki

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuhiko Naoki. A scholar is included among the top collaborators of Katsuhiko Naoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuhiko Naoki. Katsuhiko Naoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 9
3 19
4 2
5 3
6 1
7 31
8 27
9 131
10 58
11 54
12 174
13 467
14 242
15
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapybreakdown →
7539
16 55
17 40
18 30
19 14
20 43

About Katsuhiko Naoki

Katsuhiko Naoki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 125 papers that have together received 11.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (65 papers), Lung Cancer Research Studies (39 papers) and Colorectal Cancer Treatments and Studies (19 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.5k citations), Oncology (6.2k citations) and Cancer Research (2.7k citations). Katsuhiko Naoki has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Matthew Meyerson, Pasi A. Jänne, William R. Sellers, Jeffrey C. Lee, Bruce E. Johnson, Stacey Gabriel, Neal I. Lindeman, Frederic J. Kaye, Michael J. Eck and Sean Tracy. Their work appears in journals such as Science, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026